Investigators Research Group

What Investigators Research Group does

Investigators Research Group, LLC is a privately held, freestanding clinical research site network founded in 2006 and headquartered in Brownsburg, Indiana (Indianapolis metro). The company operates a single physical facility at 321 E. Northfield Drive, Suite 100, where it conducts multi-therapeutic pharmaceutical clinical trials under FDA and ethical standards, staffed by a network of board-certified principal investigators spanning Family Practice, Internal Medicine, Gastroenterology, Gynecology, Urology, Pulmonology, Endocrinology, and Dermatology.

The core product is Clinical Research Services — specifically, acting as an investigative site that recruits, enrolls, and follows study subjects across therapeutic-area protocols. Currently enrolling programs include a Type 2 Diabetes/GLP1 study (6 months, 11 visits, for uncontrolled diabetics on Semaglutide or Tirzepatide), a High Triglycerides study (48 weeks, 11 visits, for severe hypertriglyceridemia with up to $1,500 participant compensation), and a Gout study (1 year, 12 visits, for Allopurinol-treated patients). A Patient Concierge Services add-on — text reminders, transportation arrangement, and inquiry handling — supports subject retention. No proprietary technology platform is disclosed beyond a WordPress-based marketing website; the underlying technology stack is traditional site-based clinical operations.

The revenue model is professional-services grant-based. Sponsors (pharmaceutical companies, device manufacturers, government entities such as NIH) pay the site through per-subject fees, study conduct fees, and procedure reimbursements. Participants are never charged and never use insurance; they may receive compensation for time and travel plus transportation where eligible. GTM is hybrid: direct sponsor outreach for study placement with all major U.S. and international pharma companies, paired with direct-to-consumer patient recruitment via website forms, phone outreach (317-297-7999, ext. 3), and physician referrals. Headcount is reported at 1–10 employees, with no disclosed funding rounds, ownership changes, or institutional backing.

Name

Investigators Research Group

Legal name

Investigators Research Group, LLC

Website

https://investigatorsresearch.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

Investigators Research Group is a privately held, Indianapolis-area clinical research site network that conducts multi-therapeutic pharmaceutical trials for major U.S. and international pharma sponsors, recruiting patients via direct outreach and physician referrals across eight specialties.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical research services
• Pharmaceutical clinical trials
• Investigative research site
• Multi-therapeutic trials
• Medical research facility

Headquarters

HQ city

Brownsburg

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Grants: Investigators are reimbursed for all study-related procedures through grants provided by sponsoring pharmaceutical companies, device manufacturers, or government entities (such as the NIH). Revenue comes from per-subject fees, study conduct fees, and procedure reimbursements under government and industry-sponsored clinical trial agreements.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Investigators Research Group operates a freestanding, multi-therapeutic clinical research site network in the Indianapolis area that recruits volunteer participants and conducts pharmaceutical-sponsored clinical trials across specialties including Family Practice, Internal Medicine, Gastroenterology, Gynecology, Urology, Pulmonology, Endocrinology and Dermatology. Revenue is earned from pharmaceutical, device and government sponsors (e.g., NIH) through per-subject fees, study conduct fees and procedure reimbursements under clinical trial grants, while participants receive study-related care at no cost plus compensation for time and travel.

Product overview

Investigators Research Group operates as a multi-therapeutic clinical research facility in Indianapolis, Indiana, conducting pharmaceutical clinical trials. The core offering is Clinical Research Services, which encompasses enrolling studies including the Type 2 Diabetic (GLP1) Study for uncontrolled diabetics using Ozempic/Mounjaro/Zepbound, the High Triglycerides Study for patients with levels 500 or higher, and the Gout Study for patients on Allopurinol. An add-on Patient Concierge Services module provides text reminders, transportation arrangement, and question-answering to support participant engagement. The company works with pharmaceutical sponsors to place and conduct clinical trials across multiple specialties.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services Multi-therapeutic clinical trial conduct services for pharmaceutical, device, and government (e.g., NIH) sponsors, covering Family Practice, Internal Medicine, Gastroenterology, Gynecology, Urology, Pulmonology, Endocrinology, and Dermatology. Sold to trial sponsors under clinical trial grants with per-subject fees, study conduct fees, and procedure reimbursements; participants receive study-related care at no cost.
• Type 2 Diabetic (GLP1) Study Enrolling clinical trial for adults age 18–75 with uncontrolled Type 2 Diabetes currently on a stable dose of Semaglutide or Tirzepatide (Ozempic, Mounjaro, or Zepbound). Provides study-related labs, physicals, testing, and an investigational diabetic medication alongside the participant's existing therapy, plus compensation for study visits; no insurance required.
• High Triglycerides Study Enrolling clinical research study for adults age 18+ with very high triglycerides (500 or higher / severe hypertriglyceridemia) to evaluate whether an investigational medicine can safely lower blood triglyceride levels. Provides investigational medication, study-related tests and exams, compensation for time and travel up to $1,500, and transportation where eligible; insurance not required.
• Gout Study Enrolling clinical trial for adults age 18–75 diagnosed with Gout and taking Allopurinol 300mg or more daily for at least 3 months, with at least 2 gout flares in the last 12 months, BMI 18.5–45, and uric acid ≥6.5. Provides study medication plus already-approved Gout medication, study-related tests and exams, compensation for time and travel, and transportation where eligible; insurance not required.

Quantifiable outcome

• Up to $1,500 compensation for time and travel for eligible studies

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• All Major Pharmaceutical Companies in the U.S. and around the WorldcoreStrategic or Co-development PartnerInvestigators Research Group works with all major pharmaceutical companies in the U.S. and internationally to conduct clinical trials. The company serves as an investigative site for sponsored clinical research studies, providing medical oversight, subject care, and trial conduct services. The physicians in their network are all board certified in their fields of specialty and committed to the highest ethical standards.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Velocity Clinical Research: One of the largest integrated clinical research site networks in the U.S., running multi-therapeutic trials across dozens of locations. Highly comparable to Investigators Research Group as a sponsor-facing site operation, but at significantly greater scale and geographic reach.
• Javara: Integrated research organization partnering with healthcare systems to deliver clinical trials across multiple therapeutic areas. Directly comparable business model as a multi-therapeutic site network serving pharmaceutical sponsors.
• CenExel: Clinical research site network running early- and late-phase trials across multiple therapeutic areas. Directly comparable to Investigators Research Group as a site operator conducting multi-therapeutic sponsored trials, though at broader scale.
• DM Clinical Research: Multi-therapeutic clinical research site network operating across Texas and surrounding states. Comparable as a community-based site operator running sponsored pharmaceutical trials with a focus on patient recruitment.
• ProSciento: Clinical research organization specializing in metabolic disease trials including diabetes, obesity, and NASH. Especially relevant peer given Investigators Research Group's current GLP1/Type 2 Diabetes and high-triglycerides trial activity.
• Meridian Clinical Research: Multi-specialty clinical research site network running Phase I–IV trials across therapeutic areas including endocrinology and gastroenterology. Comparable as a sponsor-facing site operator with a multi-therapeutic footprint.
• Accel Research Sites: Network of clinical research sites conducting multi-therapeutic trials for pharmaceutical and device sponsors. Directly comparable business model and patient-recruitment approach to Investigators Research Group.
• IACT Health: Multi-therapeutic clinical research site network with integrated patient recruitment. Comparable to Investigators Research Group as a community-site operator running sponsored trials across multiple therapeutic areas.

Broad incumbents

• IQVIA: Global CRO and clinical research services provider that also operates site relationships and patient recruitment infrastructure. Broad incumbent that competes for the same sponsor study placements as Investigators Research Group, though at vastly greater scale.
• Medpace: Mid-to-large CRO running global clinical trials across all major therapeutic areas. Comparable as a sponsor-facing clinical trials services provider, though operating at contract-research rather than single-site scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/irg_research
• Facebookfacebook.com/Investigatorsresearch

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Investigators Research Group